Tetrahydrobenzoazepinones and related analogs for inhibiting YAP/TAZ-TEAD
US12378202B2 · kind B2 · utility
0Cited by
0References
19Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 23, 2022 |
| Grant date | Aug 5, 2025 |
| Priority date | — |
| Expiry date | Dec 23, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to novel compounds, to said compounds for use as a medicine, more in particular for the prevention or treatment of diseases mediated by activity of YAP/TAZ-TEAD transcription, yet more in particular for the prevention or treatment of cancer or fibrosis. The present disclosure also relates to a method for the prevention or treatment of said diseases comprising the use of the novel compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.